The 'epidemic' of melanoma between under- and overdiagnosis

Journal of Cutaneous Pathology

Volumn 39, Issue 1, 2012, Pages 9-16

  Weyers, Wolfgang ^a  

^a Center for Dermatopathology   (Germany)

Author keywords

epidemic; histopathology; incidence; melanoma; regression

Indexed keywords

BIOPSY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INCIDENCE; LABORATORY DIAGNOSIS; MALE; MELANOMA; MORTALITY; PATHOLOGY; REVIEW; SKIN PIGMENTATION;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; SKIN PIGMENTATION;

EID: 84855167123     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2011.01831.x     Document Type: Review

References (57)

1. The Compact Oxford English Dictionary, 2nd ed. Oxford: Clarendon Press, 1991; 524.
2. Kopf AW., The incredibly increasing incidence of malignant melanoma in the USA. Schrift Marchionini-Stiftg 1985; 9: 29.
3. Rigel DS, Russak J, Friedman R., The evolution of melanoma diagnosis: 25 years beyond the ABDCs. CA Cancer J Clin 2010; 60: 301.
4. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA., Increasing burden of melanoma in the United States. J Invest Dermatol 2009; 129: 1666.
5. Swerlick RA, Chen S., The melanoma epidemic. Is increased surveillance the solution or the problem? Arch Dermatol 1996; 132: 881.
6. Glusac EJ., The melanoma 'epidemic', a dermatopathologist's perspective. J Cutan Pathol 2011; 38: 264.
7. Welch HG, Woloshin S, Schwartz LM., Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ 2005; 331: 481.
8. Bozzo PD., There is no epidemic of melanoma!. Dermatopathology Practical and Conceptual 1998; 4: 124.
9. Ackerman AB, Cavegn BM, Abad-Casintahan F, Robinson MJ., Resolving quandaries in dermatology, pathology and dermatopathology. Philadelphia: Promethean Medical Press, 1995; 103.
10. Ackerman AB., The sun and the "epidemic" of melanoma: myth on myth, 2nd ed. New York: Ardor Scribendi, 2008.
11. Braun RP, Rabinovitz H, Tzu JE, Marghoob AA., Dermoscopy research-an update. Semin Cutan Med Surg 2009; 28: 165.
12. Argenziano G, Kittler H, Ferrara G, et al., Slow-growing melanoma: a dermoscopy follow-up study. Br J Dermatol 2010; 162: 267.
13. Ferrara G, Argenziano G, Giorgio CM, Zalaudek I, Kittler H., Dermoscopic-pathologic correlation: apropos of six equivocal cases. Semin Cutan Med Surg 2009; 28: 157.
14. Weyers W., Criteria for diagnosis of melanoma histopathologically in historical perspective. Dermatopathology: Practical and Conceptual 2002; 8: 4.
15. Price NM, Rywlin AM, Ackerman AB., Histologic criteria for the diagnosis of superficial spreading malignant melanoma: formulated on the basis of proven metastatic lesions. Cancer 1976; 38: 2434.
16. Mones JM, Ackerman AB., Melanomas in prepubescent children. Review comprehensively, critique historically, criteria diagnostically, and course biologically. Am J Dermatopathol 2003; 25: 223.
17. Kutzner H., Nested melanoma of the elderly. 31st Symposium of the International Society of Dermatopathology, Barcelona, October 22, 2010.
18. Allen AC, Spitz S., Malignant melanoma. A clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer 1953; 6: 1.
19. Reed RJ, Clark WH Jr, Mihm MC., Premalignant melanocytic dysplasias. In, Ackerman AB, ed. Pathology of malignant melanoma. New York: Masson, 1981; 159.
20. Jones RE, Cash ME, Ackerman AB., Malignant melanomas mistaken histologically for junctional nevi. In, Ackerman AB, ed. Pathology of malignant melanoma. New York: Masson, 1981; 93.
21. Resneck J, Kimball AB., The dermatology workforce shortage. J Am Acad Dermatol 2004; 50: 50.
22. Chia ALK, Shumack S., Skin cancer clinics in Australia: workload profile and performance indicators from an analysis of billing data. Med J Austr 2006; 185: 239.
23. McCalmont TH., In my opinion. J Cutan Pathol 2011; 38: 268.
24. Schmoeckel C., How consistent are dermatologists in reading early malignant melanomas and lesions "precursor" to them? Am J Dermatopathol 1984; 6: 13.
25. Farmer ER, Gonin R, Hanna MP., Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists. Hum Pathol 1996; 27: 528.
26. Cerroni L, Kerl H., Tutorial on melanocytic lesions. Am J Dermatopathol 2001; 23: 237.
27. Cerroni L, Barnhill R, Elder D, et al., Melanocytic tumors of uncertain malignant potential. Results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October, 2008. Am J Surg Pathol 2010; 34: 314.
28. Clark WH Jr, Ainsworth AM, Bernardino EA, Yang CH, Mihm MC Jr., The developmental biology of primary human malignant melanomas. Sem Oncol 1975; 2: 83.
29. Elder DE, Guerry D IV, Epstein MN, et al., Invasive malignant melanomas lacking competence for metastasis. Am J Dermatopathol 1984; 6: S55.
30. Smith KJ, Barrett TL, Skelton HG, Lupton GP, Graham JH., Spindle cell and epithelioid cell nevi with atypia and metastasis (malignant Spitz nevus). Am J Surg Pathol 1989; 13: 931.
31. Ackerman AB, Briggs PL, Bravo F., Differential diagnosis in dermatopathology III. Philadelphia, London: Lea & Febiger, 1993; 193.
32. Paul E., Growth dynamics of malignant melanoma and their relationship to melanocytic nevi as revealed by photocatamnestical investigations. Pigment cell 1988; 9: 59.
33. Saleh D, Peach AH., Ultra-late recurrence of malignant melanoma after 40 years of quiescent disease. J Surg Oncol 2011; 103: 290.
34. Ehring F., Regression von über 150 Hautmetastasen eines malignen Melanoms bei homöopathischer Komplextherapie. Hautarzt 1989; 40: 23.
35. Kalialis LV, Drzewiecki KT, Mohammadi M, Mehlsen AB, Klyver H., Spontaneous regression of metastases from malignant melanoma: a case report. Melanoma Res 2008; 18: 279.
36. Wantz M, Antonicelli F, Derancourt C, Bernard P, Avril MF, Grange F., Survie prolongée et régression tumorale sponatanée au cours de melanoma de stade IV: roles possibles de la surrénalectomie et de la libération massive d'antigÃnes tumoraux. Ann Dermatol Venereol 2010; 137: 464.
37. Fabrizi G, Massi G., Spitzoid malignant melanoma in teenagers: an entity with no better prognosis than that of other forms of melanoma. Histopathology 2001; 38: 448.
38. Linabery AM, Ross JA., Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 2008; 112: 416.
39. Swetter SM, Boldrick JC, Pierre P, Wong P, Egbert BM., Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas: rate of tumor regression in excisional specimens. J Cutan Pathol 2003; 30: 139.
40. Hoption Cann SA, van Netten JP, van Netten C, Glover DW., Spontaneous regression: a hidden treasure buried in time. Med Hypotheses 2002; 58: 115.
41. Kurita M, Hirano K, Ebihara S, et al., Spontaneous regression of cervical lymph node metastasis in a patient with squamous cell carcinoma of the tongue: possible association between apoptosis and tumor regression. Int J Clin Oncol 2007; 12: 448.
42. Kojima H, Tanigawa N, Kariya S, et al., A case of spontaneous regression of hepatocellular carcinoma with multiple lung metastases. Radiat Med 2006; 24: 139.
43. Christophersen AO, Lie AK., Fosså SD. Unexpected 10 years complete remission after cortisone mono-therapy in metastatic renal cell carcinoma. Acta Oncol 2006; 45: 226.
44. Musser JE, Przybycin CG, Russo P., Regression of metastatic seminoma in a patient referred for carcinoma of unknown primary origin. Nat Rev Urol 2010; 7: 466.
45. Wooff JC, Trites JR, Walsh NMG, Bullock MJ., Complete spontaneous regression of metastatic Merkel cell carcinoma: a case report and review of the literature. Am J Dermatopathol 2010; 32: 614.
46. Anbari KK, Schuchter LM, Bucky LP, et al., Melanoma of unknown primary site: presentation, treatment, and prognosis-a single institution study. Cancer 1997; 79: 1816.
47. O'Neill JK, Khundar R, Knowles L, et al., Melanoma with an unknown primary-a case series. J Plast Reconstr Aesthet Surg 2010; 63: 2071.
48. Savoia P, Fava P, Osella-Abate S, et al., Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre. Melanoma Res 2010; 20: 227.
49. Kaye VN, Dehner LP., Spindle and epithelioid cell nevus (Spitz nevus). Natural history following biopsy. Arch Dermatol 1990; 126: 1581.
50. Gambini C, Rongioletti F., Recurrent Spitz nevus. Case report and review of the literature. Am J Dermatopathol 1994; 16: 409.
51. Rademaker M, Thorburn M., Pathology referrals for skin lesions-are we giving the pathologist sufficient clinical information?. N Z Med J 2010; 123: 53.
52. Tronnier M, Wolff HH., UV-irradiated melanocytic nevi simulating melanoma in situ. Am J Dermatopathol 1995; 17: 1.
53. Schmid-Wendtner MH, Baumert J, Plewig G, Volkenandt M., Seasonal variations in the diagnosis of cutaneous nmelanoma. J Am Acad Dermatol 2004; 50: 679.
54. Witheiler DD, Cockerell CJ., Sensitivity of diagnosis of malignant melanoma: a clinicopathologic study with a critical assessment of biopsy techniques. Exp Dermatol 1992; 1: 170.
55. Ng JC, Swain S, Dowling JP, Wolfe R, Simpson P, Kelly JW., The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service. Arch Dermatol 2010; 146: 234.
56. Epstein E, Bragg K, Linden G., Biopsy and prognosis of malignant melanoma. JAMA 1969; 208: 1369.
57. Lederman JS, Sober AJ., Does biopsy type influence survival in clinical stage I cutaneous melanoma?. J Am Acad Dermatol 1985; 13: 983.